Skip to content

Psychological Treatment in Psychiatric Inpatient Care

Psychological Treatment in Psychiatric Inpatient Care

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06012981
Enrollment
1
Registered
2023-08-28
Start date
2023-09-01
Completion date
2023-11-15
Last updated
2023-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acceptance & Commitment Therapy, Compulsory Psychiatric Care Act, Psychiatric Disorder, Psychiatric Hospitalization, Psychosis

Brief summary

This study aims to investigate the effect of a brief psychotherapeutic treatment intervention based on ACT, aimed specifically at the vulnerable group of patients in psychiatric 24-hour care treated according to LPT. The study aims to investigate whether a brief number of therapeutic sessions according to ACT during inpatient care produce positive effects on personally relevant life areas for a diagnostically mixed group of patients in a psychiatric intensive care unit.

Interventions

BEHAVIORALACT

The treatment is based on a variant of CBT, as briefly referred to before, ACT. In short, the treatment consists of identifying central and important areas of life, and how to approach these even though you are also struggling with persistent and challenging problems. In this study, the treatment intervention is flexibly constructed, focusing on several central principles based on ACT. These can be applied during one or numerous sessions. The intervention is a flexible application of clinical functional analysis, as well as a couple of selected interventions which, in terms of experience and in previous studies, have been shown to work well for the current group (24-hour psychiatric patients with complex problems) and which are individually adaptable to the nature of the problem and degree.

Sponsors

Uppsala University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Single-case experimental design.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years old or older. * Treated according to the compulsory psychiatric care act. * Meet the criterion of informed consent.

Exclusion criteria

* Lack the cognitive ability to acquire the treatment intervention, such as impaired attention, memory, logic and reasoning, and also auditory and visual processing. This will be based on a clinical assessment by the ward team, including the attending psychiatrist and a clinical psychologist. * Ongoing psychological treatment parallel to the admission.

Design outcomes

Primary

MeasureTime frameDescription
Change in Personal QuestionnaireFour times daily, from point of inclusion to after a minimum of five data points (approximately a day and a half) after last treatment sessionScores range from 1-4 per item (number of items might differ between patients as the measure is individually constructed. Higher scores correspond to worse outcome.
Change in Bull's Eye Values SurveyFour times daily, from point of inclusion to after a minimum of five data points (approximately a day and a half) after last treatment sessionThe score ranges from 0-28, higher scores corresponding to better outcome.
Change in PHQ-9Four times daily, from point of inclusion to after a minimum of five data points (approximately a day and a half) after last treatment sessionThe score ranges from 0-27, higher scores corresponding to worse outcome.
Change in GAD-7Four times daily, from point of inclusion to after a minimum of five data points (approximately a day and a half) after last treatment sessionThe score ranges from 0-21, higher scores corresponding to worse outcome.
Change in Psy-flexFour times daily, from point of inclusion to after a minimum of five data points (approximately a day and a half) after last treatment sessionThe score ranges from 6-30, higher scores corresponding to better outcome.

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026